SlideShare a Scribd company logo
1 of 7
Computational Structure-based  Drug Design ,[object Object],[object Object],Molecular Modelling Mini Tutorial
Discovery of a new drug is  a long and costly process Time 20 - 40 Months Value 2.5 – 7 Millions Source: Bogdan, B and Villiger, R. Valuation in Life Sciences, 2007, Springer Molecular Modelling Mini Tutorial Target  Validation Lead optimization Hit discovery
The risk of failure is very high Drug development success rates Reasons of abandonment Source: Bogdan, B and Villiger, R. Valuation in Life Sciences, 2007, Springer Molecular Modelling Mini Tutorial 15.8% Oncology 28.1% Infections 15.4% Immunology 17.5% Cardio vascular 14.5% Central nervous system Rate Disease Group 9.0% Other 19.6% Safety 33.8% Economics 37.6% Efficacy Rate Reason
Molecular Modelling can help to reduce the drug development time and risk of failure Computational chemical and structural biology applied to: Molecular Modelling Mini Tutorial ,[object Object],[object Object],[object Object],[object Object]
Innovative drug development platforms Fragment-based drug design approach One of the most important advance in drug discovery Drug candidates are  built inside the target  binding site using  small molecule fragments Lead fragment Fragment grow Drug candidate Micromolar affinity Millimolar affinity nanomolar affinity Molecular Modelling Mini Tutorial Target structure Target structure Target structure
Detailed target:drug candidate structural characterization Molecular Modelling Mini Tutorial Support you Medicinal Chemistry  decisions with our structural and  modelling information Get a structural picture of how  your drug candidates interact  with your target
Molecular Modelling can support your  research & development effort on: ,[object Object],[object Object],[object Object],[object Object],[object Object],Molecular Modelling Mini Tutorial Dr. Nuno Micaelo Researcher, Aveiro University [email_address]

More Related Content

What's hot

Computer aided drug design
Computer aided drug designComputer aided drug design
Computer aided drug design
N K
 

What's hot (20)

Homology modelling
Homology modellingHomology modelling
Homology modelling
 
Molecular modelling and docking studies
Molecular modelling and docking studiesMolecular modelling and docking studies
Molecular modelling and docking studies
 
Structure based drug design
Structure based drug designStructure based drug design
Structure based drug design
 
Molecular modelling
Molecular modellingMolecular modelling
Molecular modelling
 
molecular docking its types and de novo drug design and application and softw...
molecular docking its types and de novo drug design and application and softw...molecular docking its types and de novo drug design and application and softw...
molecular docking its types and de novo drug design and application and softw...
 
Pharmacophore identification
Pharmacophore identificationPharmacophore identification
Pharmacophore identification
 
Computer aided drug design
Computer aided drug designComputer aided drug design
Computer aided drug design
 
Homology modeling
Homology modelingHomology modeling
Homology modeling
 
Structure based drug designing
Structure based drug designingStructure based drug designing
Structure based drug designing
 
Computer Aided Drug Design ppt
Computer Aided Drug Design pptComputer Aided Drug Design ppt
Computer Aided Drug Design ppt
 
Docking
DockingDocking
Docking
 
Pharmacophore mapping in Drug Development
Pharmacophore mapping in Drug DevelopmentPharmacophore mapping in Drug Development
Pharmacophore mapping in Drug Development
 
Virtual Screening in Drug Discovery
Virtual Screening in Drug DiscoveryVirtual Screening in Drug Discovery
Virtual Screening in Drug Discovery
 
Quantitative Structure Activity Relationship
Quantitative Structure Activity RelationshipQuantitative Structure Activity Relationship
Quantitative Structure Activity Relationship
 
Computer aided drug design
Computer aided drug designComputer aided drug design
Computer aided drug design
 
STRUCTURE BASED DRUG DESIGN - MOLECULAR MODELLING AND DRUG DISCOVERY
STRUCTURE BASED DRUG DESIGN - MOLECULAR MODELLING AND DRUG DISCOVERYSTRUCTURE BASED DRUG DESIGN - MOLECULAR MODELLING AND DRUG DISCOVERY
STRUCTURE BASED DRUG DESIGN - MOLECULAR MODELLING AND DRUG DISCOVERY
 
STRUCTURE BASED DRUG DESIGN.pptx
STRUCTURE BASED DRUG DESIGN.pptxSTRUCTURE BASED DRUG DESIGN.pptx
STRUCTURE BASED DRUG DESIGN.pptx
 
Basics Of Molecular Docking
Basics Of Molecular DockingBasics Of Molecular Docking
Basics Of Molecular Docking
 
Molecular docking and_virtual_screening
Molecular docking and_virtual_screeningMolecular docking and_virtual_screening
Molecular docking and_virtual_screening
 
Drug design
Drug designDrug design
Drug design
 

Similar to Structure Based Drug Design

Myelin repair open science summit 07.31.10 v2
Myelin repair   open science summit 07.31.10 v2Myelin repair   open science summit 07.31.10 v2
Myelin repair open science summit 07.31.10 v2
Open Science Summit
 
Application of Machine Learning in Drug Discovery and Development Lifecycle
Application of Machine Learning in Drug Discovery and Development LifecycleApplication of Machine Learning in Drug Discovery and Development Lifecycle
Application of Machine Learning in Drug Discovery and Development Lifecycle
AI Publications
 
Application of Machine Learning in Drug Discovery and Development Lifecycle
Application of Machine Learning in Drug Discovery and Development LifecycleApplication of Machine Learning in Drug Discovery and Development Lifecycle
Application of Machine Learning in Drug Discovery and Development Lifecycle
AI Publications
 
Applications Of Bioinformatics In Drug Discovery And Process
Applications Of Bioinformatics In Drug Discovery And ProcessApplications Of Bioinformatics In Drug Discovery And Process
Applications Of Bioinformatics In Drug Discovery And Process
Prof. Dr. Basavaraj Nanjwade
 

Similar to Structure Based Drug Design (20)

Myelin repair open science summit 07.31.10 v2
Myelin repair   open science summit 07.31.10 v2Myelin repair   open science summit 07.31.10 v2
Myelin repair open science summit 07.31.10 v2
 
Immunogenicity Summit 2013
Immunogenicity Summit 2013Immunogenicity Summit 2013
Immunogenicity Summit 2013
 
Berg_04_04.ppt
Berg_04_04.pptBerg_04_04.ppt
Berg_04_04.ppt
 
Various Computational Tools used in Drug Design
Various Computational Tools used in Drug DesignVarious Computational Tools used in Drug Design
Various Computational Tools used in Drug Design
 
Computer aided drug design - a new drug discovery tool
Computer aided drug design - a new drug discovery toolComputer aided drug design - a new drug discovery tool
Computer aided drug design - a new drug discovery tool
 
Molecular docking and its importance in drug design
Molecular docking and its importance in drug designMolecular docking and its importance in drug design
Molecular docking and its importance in drug design
 
Role of bioinformatics in drug designing
Role of bioinformatics in drug designingRole of bioinformatics in drug designing
Role of bioinformatics in drug designing
 
13th Annual World Pharma Congress [Full Agenda]
13th Annual World Pharma Congress [Full Agenda]13th Annual World Pharma Congress [Full Agenda]
13th Annual World Pharma Congress [Full Agenda]
 
MedImmune Industrial Placement Student Programme 2016
MedImmune Industrial Placement Student Programme 2016MedImmune Industrial Placement Student Programme 2016
MedImmune Industrial Placement Student Programme 2016
 
MDC Connect: In-Silico Drug Design - what to do, what not to do - project dri...
MDC Connect: In-Silico Drug Design - what to do, what not to do - project dri...MDC Connect: In-Silico Drug Design - what to do, what not to do - project dri...
MDC Connect: In-Silico Drug Design - what to do, what not to do - project dri...
 
computational chemistry
computational chemistrycomputational chemistry
computational chemistry
 
Discovery on Target 2014 - The Industry's Preeminent Event on Novel Drug Targets
Discovery on Target 2014 - The Industry's Preeminent Event on Novel Drug TargetsDiscovery on Target 2014 - The Industry's Preeminent Event on Novel Drug Targets
Discovery on Target 2014 - The Industry's Preeminent Event on Novel Drug Targets
 
Application of Machine Learning in Drug Discovery and Development Lifecycle
Application of Machine Learning in Drug Discovery and Development LifecycleApplication of Machine Learning in Drug Discovery and Development Lifecycle
Application of Machine Learning in Drug Discovery and Development Lifecycle
 
Application of Machine Learning in Drug Discovery and Development Lifecycle
Application of Machine Learning in Drug Discovery and Development LifecycleApplication of Machine Learning in Drug Discovery and Development Lifecycle
Application of Machine Learning in Drug Discovery and Development Lifecycle
 
Bioinformatics ( Dharal Mistry ) M.Pharm
Bioinformatics ( Dharal Mistry ) M.PharmBioinformatics ( Dharal Mistry ) M.Pharm
Bioinformatics ( Dharal Mistry ) M.Pharm
 
Software Used In Formulation Design Process (Pharmaceutics).Pdf
Software Used In Formulation Design Process (Pharmaceutics).PdfSoftware Used In Formulation Design Process (Pharmaceutics).Pdf
Software Used In Formulation Design Process (Pharmaceutics).Pdf
 
CHI's Immunogenicity and Bioassay Summit 2015
CHI's Immunogenicity and Bioassay Summit 2015CHI's Immunogenicity and Bioassay Summit 2015
CHI's Immunogenicity and Bioassay Summit 2015
 
Applications Of Bioinformatics In Drug Discovery And Process
Applications Of Bioinformatics In Drug Discovery And ProcessApplications Of Bioinformatics In Drug Discovery And Process
Applications Of Bioinformatics In Drug Discovery And Process
 
Drug design and toxicology
Drug design and toxicologyDrug design and toxicology
Drug design and toxicology
 
SMi Group's Drug Discovery Chemistry
SMi Group's Drug Discovery ChemistrySMi Group's Drug Discovery Chemistry
SMi Group's Drug Discovery Chemistry
 

More from nmicaelo (10)

Dicas do Catálogo Oriflame de Natal 2017
Dicas do Catálogo Oriflame de Natal 2017Dicas do Catálogo Oriflame de Natal 2017
Dicas do Catálogo Oriflame de Natal 2017
 
Apresentação do Catálogo 9 Oriflame
Apresentação do Catálogo 9 OriflameApresentação do Catálogo 9 Oriflame
Apresentação do Catálogo 9 Oriflame
 
Catálogo 2 oriflame
Catálogo 2 oriflameCatálogo 2 oriflame
Catálogo 2 oriflame
 
Apresentação do catálogo 16 oriflame
Apresentação do catálogo 16 oriflameApresentação do catálogo 16 oriflame
Apresentação do catálogo 16 oriflame
 
Novidades do catálogo 14 oriflame
Novidades do catálogo 14 oriflameNovidades do catálogo 14 oriflame
Novidades do catálogo 14 oriflame
 
Oriflame Catálogo 7 2016
Oriflame Catálogo 7 2016Oriflame Catálogo 7 2016
Oriflame Catálogo 7 2016
 
catálogo 6 Oriflame
catálogo 6 Oriflamecatálogo 6 Oriflame
catálogo 6 Oriflame
 
Catálogo 6 Oriflame
Catálogo 6 OriflameCatálogo 6 Oriflame
Catálogo 6 Oriflame
 
Campanhas catálogo 3 Oriflame
Campanhas catálogo 3 OriflameCampanhas catálogo 3 Oriflame
Campanhas catálogo 3 Oriflame
 
Protein Engineering
Protein EngineeringProtein Engineering
Protein Engineering
 

Recently uploaded

Tales from a Passkey Provider Progress from Awareness to Implementation.pptx
Tales from a Passkey Provider  Progress from Awareness to Implementation.pptxTales from a Passkey Provider  Progress from Awareness to Implementation.pptx
Tales from a Passkey Provider Progress from Awareness to Implementation.pptx
FIDO Alliance
 
Harnessing Passkeys in the Battle Against AI-Powered Cyber Threats.pptx
Harnessing Passkeys in the Battle Against AI-Powered Cyber Threats.pptxHarnessing Passkeys in the Battle Against AI-Powered Cyber Threats.pptx
Harnessing Passkeys in the Battle Against AI-Powered Cyber Threats.pptx
FIDO Alliance
 

Recently uploaded (20)

Introduction to FIDO Authentication and Passkeys.pptx
Introduction to FIDO Authentication and Passkeys.pptxIntroduction to FIDO Authentication and Passkeys.pptx
Introduction to FIDO Authentication and Passkeys.pptx
 
Intro to Passkeys and the State of Passwordless.pptx
Intro to Passkeys and the State of Passwordless.pptxIntro to Passkeys and the State of Passwordless.pptx
Intro to Passkeys and the State of Passwordless.pptx
 
Tales from a Passkey Provider Progress from Awareness to Implementation.pptx
Tales from a Passkey Provider  Progress from Awareness to Implementation.pptxTales from a Passkey Provider  Progress from Awareness to Implementation.pptx
Tales from a Passkey Provider Progress from Awareness to Implementation.pptx
 
AI mind or machine power point presentation
AI mind or machine power point presentationAI mind or machine power point presentation
AI mind or machine power point presentation
 
(Explainable) Data-Centric AI: what are you explaininhg, and to whom?
(Explainable) Data-Centric AI: what are you explaininhg, and to whom?(Explainable) Data-Centric AI: what are you explaininhg, and to whom?
(Explainable) Data-Centric AI: what are you explaininhg, and to whom?
 
ERP Contender Series: Acumatica vs. Sage Intacct
ERP Contender Series: Acumatica vs. Sage IntacctERP Contender Series: Acumatica vs. Sage Intacct
ERP Contender Series: Acumatica vs. Sage Intacct
 
Google I/O Extended 2024 Warsaw
Google I/O Extended 2024 WarsawGoogle I/O Extended 2024 Warsaw
Google I/O Extended 2024 Warsaw
 
Introduction to FDO and How It works Applications _ Richard at FIDO Alliance.pdf
Introduction to FDO and How It works Applications _ Richard at FIDO Alliance.pdfIntroduction to FDO and How It works Applications _ Richard at FIDO Alliance.pdf
Introduction to FDO and How It works Applications _ Richard at FIDO Alliance.pdf
 
Intro in Product Management - Коротко про професію продакт менеджера
Intro in Product Management - Коротко про професію продакт менеджераIntro in Product Management - Коротко про професію продакт менеджера
Intro in Product Management - Коротко про професію продакт менеджера
 
The Value of Certifying Products for FDO _ Paul at FIDO Alliance.pdf
The Value of Certifying Products for FDO _ Paul at FIDO Alliance.pdfThe Value of Certifying Products for FDO _ Paul at FIDO Alliance.pdf
The Value of Certifying Products for FDO _ Paul at FIDO Alliance.pdf
 
WebAssembly is Key to Better LLM Performance
WebAssembly is Key to Better LLM PerformanceWebAssembly is Key to Better LLM Performance
WebAssembly is Key to Better LLM Performance
 
Event-Driven Architecture Masterclass: Engineering a Robust, High-performance...
Event-Driven Architecture Masterclass: Engineering a Robust, High-performance...Event-Driven Architecture Masterclass: Engineering a Robust, High-performance...
Event-Driven Architecture Masterclass: Engineering a Robust, High-performance...
 
1111 ChatGPT Prompts PDF Free Download - Prompts for ChatGPT
1111 ChatGPT Prompts PDF Free Download - Prompts for ChatGPT1111 ChatGPT Prompts PDF Free Download - Prompts for ChatGPT
1111 ChatGPT Prompts PDF Free Download - Prompts for ChatGPT
 
Where to Learn More About FDO _ Richard at FIDO Alliance.pdf
Where to Learn More About FDO _ Richard at FIDO Alliance.pdfWhere to Learn More About FDO _ Richard at FIDO Alliance.pdf
Where to Learn More About FDO _ Richard at FIDO Alliance.pdf
 
Harnessing Passkeys in the Battle Against AI-Powered Cyber Threats.pptx
Harnessing Passkeys in the Battle Against AI-Powered Cyber Threats.pptxHarnessing Passkeys in the Battle Against AI-Powered Cyber Threats.pptx
Harnessing Passkeys in the Battle Against AI-Powered Cyber Threats.pptx
 
Using IESVE for Room Loads Analysis - UK & Ireland
Using IESVE for Room Loads Analysis - UK & IrelandUsing IESVE for Room Loads Analysis - UK & Ireland
Using IESVE for Room Loads Analysis - UK & Ireland
 
Oauth 2.0 Introduction and Flows with MuleSoft
Oauth 2.0 Introduction and Flows with MuleSoftOauth 2.0 Introduction and Flows with MuleSoft
Oauth 2.0 Introduction and Flows with MuleSoft
 
ASRock Industrial FDO Solutions in Action for Industrial Edge AI _ Kenny at A...
ASRock Industrial FDO Solutions in Action for Industrial Edge AI _ Kenny at A...ASRock Industrial FDO Solutions in Action for Industrial Edge AI _ Kenny at A...
ASRock Industrial FDO Solutions in Action for Industrial Edge AI _ Kenny at A...
 
Your enemies use GenAI too - staying ahead of fraud with Neo4j
Your enemies use GenAI too - staying ahead of fraud with Neo4jYour enemies use GenAI too - staying ahead of fraud with Neo4j
Your enemies use GenAI too - staying ahead of fraud with Neo4j
 
Portal Kombat : extension du réseau de propagande russe
Portal Kombat : extension du réseau de propagande russePortal Kombat : extension du réseau de propagande russe
Portal Kombat : extension du réseau de propagande russe
 

Structure Based Drug Design

  • 1.
  • 2. Discovery of a new drug is a long and costly process Time 20 - 40 Months Value 2.5 – 7 Millions Source: Bogdan, B and Villiger, R. Valuation in Life Sciences, 2007, Springer Molecular Modelling Mini Tutorial Target Validation Lead optimization Hit discovery
  • 3. The risk of failure is very high Drug development success rates Reasons of abandonment Source: Bogdan, B and Villiger, R. Valuation in Life Sciences, 2007, Springer Molecular Modelling Mini Tutorial 15.8% Oncology 28.1% Infections 15.4% Immunology 17.5% Cardio vascular 14.5% Central nervous system Rate Disease Group 9.0% Other 19.6% Safety 33.8% Economics 37.6% Efficacy Rate Reason
  • 4.
  • 5. Innovative drug development platforms Fragment-based drug design approach One of the most important advance in drug discovery Drug candidates are built inside the target binding site using small molecule fragments Lead fragment Fragment grow Drug candidate Micromolar affinity Millimolar affinity nanomolar affinity Molecular Modelling Mini Tutorial Target structure Target structure Target structure
  • 6. Detailed target:drug candidate structural characterization Molecular Modelling Mini Tutorial Support you Medicinal Chemistry decisions with our structural and modelling information Get a structural picture of how your drug candidates interact with your target
  • 7.